MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Impulse control disorder in early Parkinson’s disease: Follow-up study

    V. Markovic, I. Stankovic, I. Petrovic, T. Stojkovic, M. Jecmenica-Lukic, A. Tomic, V. Kostic (Belgrade, Serbia)

    Objective: To assess frequency of impulse control disorder (ICD) in a cohort of patients with early stage of Parkinson's disease (PD), to analyze clinical and…
  • 2016 International Congress

    Technology use and impulse control disorders (ICDs) in patients with Parkinson’s disease (PD)

    E.A. Byrd, C.M. Tanner, C.A. Racine, N.B. Galifianakis (San Francisco, CA, USA)

    Objective: To ascertain the prevalence of problematic technology use (Technology-related ICDs, Tech-ICDs) in patients with PD. Background: ICDs are a known complication of PD drugs…
  • 2016 International Congress

    Phenotypic spectrum and longitudinal outcome of Parkinson’s disease patients with psychosis

    M.S. Nanjunda Swamy, M.M. Abbas, S.T. Govindappa, P. Basu, R. Ramanathan, U.B. Muthane (Bangalore, India)

    Objective: We studied the phenotypic characteristics of psychosis in PD patients, their associated risk factors and assessed their long term outcome. Background: Psychosis in PD…
  • 2016 International Congress

    Impulse control disorder in Parkinson’s disease is not related to lower cognitive performance

    J. Marin-Lahoz, R. Fernandez-Bobadilla, J. Pagonabarraga, S. Martinez-Horta, B. Pascual-Sedano, J. Perez-Perez, H. Bejr-Kasem, A. Gironell, J. Kulisevsky (Barcelona, Spain)

    Objective: To compare cognitive performance in patients with and without Impulse Control Disorders (ICD) according to MDS recommendations for Parkinson's disease (PD) Mild Cognitive Impairment…
  • 2016 International Congress

    Neuropsychiatric, personality and non-motor correlates of impulse control disorders in recent onset Parkinson’s disease

    D.M.A. Swallow, M.A. Lawton, K.A. Grosset, N. Malek, N. Bajaj, R.A. Barker, Y. Ben-Shlomo, D.J. Burn, T. Foltynie, J. Hardy, H.R. Morris, N. Williams, N.W. Wood, D.G. Grosset, PRoBaND Collaborators (Glasgow, United Kingdom)

    Objective: To record the prevalence and clinical correlates of impulse control disorders (ICDs) in recent onset Parkinson's disease (PD) cases in the Tracking Parkinson's (PRoBaND)…
  • 2016 International Congress

    Volition and action control in Parkinson’s disease patients with impulsive-compulsive behaviour disorders

    L. Ricciardi, P. Haggard, L. de Boer, C. Sorbera, M.P. Stenner, F. Morgante, M.J. Edwards (London, United Kingdom)

    Objective: We aimed to explore different aspects of action control, assessing reward-related behaviour, inhibition (externally and internally triggered) and sense of agency in Parkinson's disease…
  • 2016 International Congress

    Feasibility and effectiveness of a low-threshold psychoeducative group-intervention for depression in Parkinson’s disease

    K. Linse, M. Fauser, C. Ossig, A. Hermann, A. Storch (Dresden, Germany)

    Objective: To evaluate a low-threshold psychoeducative group-intervention for depression in idiopathic Parkinson's disease (PD). Background: Up to 40% of PD-patients suffer from clinically relevant depression…
  • 2016 International Congress

    The cerebral structural and functional signatures of impulse control disorder in Parkinson’s disease

    F. Imperiale, F. Agosta, E. Canu, V. Špica, M. Jecmenica, M. Copetti, V.S. Kostic, M. Filippi (Milan, Italy)

    Objective: To assess cortical thickness (CT) measures, white matter (WM) microstructural damage, and resting state (RS) functional connectivity alterations in patients with Parkinson's disease and…
  • 2016 International Congress

    Screening for neuropsychiatric symptoms in Parkinson’s disease

    M.J. Barrett, S.A. Sperling, B.B. Shah, J.L. Flanigan, G.F. Wooten, M.B. Harrison, C.A. Manning (Charlottesville, VA, USA)

    Objective: To determine the convergent validity of the screening questions included in instructions to patients for Part 1A of the International Parkinson and Movement Disorder…
  • 2016 International Congress

    Coping styles and their influence on outcomes in Parkinson’s disease

    K.M. Sundvick, F. Kassam, N. Dispirito, E. Book, S. Cresswell (Vancovuer, BC, Canada)

    Objective: To understand the associations between coping styles and various clinical symptoms and outcomes in patients with Parkinson's disease (PD). Background: The diagnosis of a…
  • « Previous Page
  • 1
  • …
  • 1671
  • 1672
  • 1673
  • 1674
  • 1675
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley